Stay updated with breaking news from Agile therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indivior (NASDAQ:INDV – Get Free Report) and Agile Therapeutics (NASDAQ:AGRX – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 60.3% of Indivior shares are […] ....
Biomea Fusion (NASDAQ:BMEA – Get Free Report) and Agile Therapeutics (NASDAQ:AGRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Biomea Fusion has a […] ....
Marker Therapeutics (NASDAQ:MRKR – Get Rating) and Agile Therapeutics (NASDAQ:AGRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Analyst Ratings This is a breakdown of current ratings […] ....
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) – Stock analysts at HC Wainwright issued their FY2023 earnings per share estimates for Agile Therapeutics in a research report issued to clients and investors on Wednesday, June 7th. HC Wainwright analyst O. Livnat anticipates that the specialty pharmaceutical company will post earnings per share of ($6.05) for […] ....